secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2023-09-06T23:59:59+00:00
Accession:  0001493152-23-031741
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix to present positive UroShield study at ICS 2023; reduces CAUTI and blockages
--------------------------------------------------------------------------------

- Dr. Sandra Wilks to present UroShield study at ICS 2023 in Toronto on September 27.
- University of Southampton study shows UroShield reduces catheter-associated urinary tract infections and blockages.
- Study suggests UroShield may promote healthy urinary microbiome and reduce antibiotic use.
- UroShield uses low-frequency ultrasound to prevent bacterial biofilm on catheters.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315223031741/0001493152-23-031741-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315223031741/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-031741

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer